Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 282

Sort by

Sort Order Select

Journal Articles

High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial

Zinan Feng, Yu Zhang, Hui Liu, Sijian Yu, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 972.

https://doi.org/10.1182/blood-2024-200583

Published: 2024

Journal Articles

TET2 Deficiency Cooperates with MSH6 Mutation to Promote the Progression of MDS/MPN through Increasing Tumor Stem Cell Frequency

Yangpeng Chen, Haoyuan Li, Mingjiang Xu, Qifa Liu

Blood (2024) 144 (Supplement 1): 6579.

https://doi.org/10.1182/blood-2024-209187

Published: 2024

Journal Articles

Ursolic Acid Alleviates the Injurious Effects of Busulfan Plus Cyclophosphamide on Hepatic Sinusoidal Endothelial Cells By Inhibiting the TNFα/NF-Κb Signaling Pathway

Jie Wei, Qifa Liu, Rongrong Liu

Blood (2024) 144 (Supplement 1): 7312.

https://doi.org/10.1182/blood-2024-205405

Published: 2024

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Blood (2024) 144 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2024-205021

Published: 2024

Journal Articles

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Xiao Liang, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhenbin Wei, Yumei Huang, Jing Bai, Yi Liang, Lingyuan Pan, Zhaoping Gan, Yu Lin, Yibin Yao, Ying Tang, Huicheng Huang, Xuemei Zhou, Qifa Liu, Yongrong Lai, Rongrong Liu

Blood (2024) 144 (Supplement 1): 1096.

https://doi.org/10.1182/blood-2024-204971

Published: 2024

Journal Articles

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Han Yao, Xiaoqi Wang, Ruihao Huang, Yimei Feng, Xiaojuan Deng, Ting Chen, Lidan Zhu, Jia Liu, Yuqing Liu, Lu Zhao, Lu Wang, Cheng Zhang, Peiyan Kong, Li Gao, Lei Gao, Qifa Liu, Xiaohui Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 7122.

https://doi.org/10.1182/blood-2024-206679

Published: 2024

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

Intensified Conditioning Containing Decitabine Versus Standard Myeloablative Conditioning for Adult Patients with KMT2A-Rearranged Leukemia: A Multicenter Retrospective Study

Zhongli Hu, Hai He, Shiqi Liu, Ying Dong, Zhiping Fan, Yiqing Li, Fen Huang, Na Xu, Can Liu, Yunxin Zeng, Ping Zhu, Ren Lin, Hua Jin, Xiong Zhang, Ruijuan Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 2123.

https://doi.org/10.1182/blood-2024-202822

Published: 2024

Journal Articles

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

Hongwen Xiao, Gaohui Yang, Qiuling Huang, Zhenbin Wei, Zhaoping Gan, Meiqing Wu, Zeyan Shi, Huicheng Huang, Zhaofang Pan, Lianjin Liu, Lingling Shi, Zhongming Zhang, Qifa Liu, Rongrong Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2139.

https://doi.org/10.1182/blood-2024-205258

Published: 2024

Journal Articles

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Qiuling Huang, Rongrong Liu, Lianjin Liu, Meiqing Wu, Lingling Shi, Gaohui Yang, Zhongming Zhang, Qifa Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2024-205204

Published: 2024

Journal Articles

Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study

Hu Yingying, Xuan Zhou, Shuhua Li, Jing Sun, Jieyu Ye, Qifa Liu, Houmei Feng

Blood (2024) 144 (Supplement 1): 3979.

https://doi.org/10.1182/blood-2024-206976

Published: 2024

Journal Articles

Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

Jieping Lin, Chenhao Ding, Zicong Huang, Cai Zihong, Jia Li, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou

Blood (2024) 144 (Supplement 1): 839.

https://doi.org/10.1182/blood-2024-200513

Published: 2024

Journal Articles

Clinical Characteristics and Risk Factors of Chronic Kidney Disease Among Patients with Myeloproliferative Neoplasms

Zicheng Gao, Xuan Zhou, Qiang Wang, Dan Xu, Xiaoli Liu, Na Xu, Qifa Liu

Blood (2024) 144 (Supplement 1): 6643.

https://doi.org/10.1182/blood-2024-207289

Published: 2024

Journal Articles

Quantitative Detection of the Expressions of BCL-2, BCL-Xl and MCL-1 in Bone Marrow Tissues with Immunofluorescence Might Predict the Efficacy of Venetoclax-Based Therapies in Acute Myeloid Leukemia

Xiaqi Nie, Zhao Yin, Zurong Yao, Dandan Chen, Qifa Liu, Guopan Yu

Blood (2024) 144 (Supplement 1): 6109.

https://doi.org/10.1182/blood-2024-208001

Published: 2024

Journal Articles

Drug-Resistant Hematological Malignancies Organoids Can be Established By Magic-PDX Model Strategy

Lingxi Chen, Lichuan Jiang, Yongzhen Lin, Luxia Tang, Lihan Dai, Ruohan Weng, Hongfei Zhu, Minghu Liao, Qifa Liu, Qianli Jiang

Blood (2024) 144 (Supplement 1): 5804.

https://doi.org/10.1182/blood-2024-205078

Published: 2024

Journal Articles

ABC Regimen: Combination of 3rd Generation TKI Olverembatinib, Blinatumomab and Chidamide for Older New Diagnosed Ph-Positive ALL Patients

Junjie Chen, Hongsheng Zhou, Qifa Liu

Blood (2024) 144 (Supplement 1): 5881.

https://doi.org/10.1182/blood-2024-200685

Published: 2024

Journal Articles

BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL

Jieping Lin, Xuan Zhou, Zhixiang Wang, Dainan Lin, Yu Zhan, Zan Li, Jiwei Huang, Yonghua Li, Xudong Ma, Qifa Liu, Li Xuan, Yang Xu, Hongsheng Zhou

Blood (2024) 144 (Supplement 1): 5901.

https://doi.org/10.1182/blood-2024-203250

Published: 2024

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Blood (2024) 144 (Supplement 1): 4196.

https://doi.org/10.1182/blood-2024-199983

Published: 2024

Journal Articles

Donor Neutrophil Subsets in G-CSF Mobilized Peripheral Blood Stem Cell to Predict the Risk of Agvhd

Haiyan Zhang, Qiaoyuan Wu, Huajuan Dai, Xinyu Liu, Zhiping Fan, Ren Lin, Na Xu, Qianwei Liu, Qifa Liu, Hua Jin

Blood (2024) 144 (Supplement 1): 4910.

https://doi.org/10.1182/blood-2024-204754

Published: 2024

Journal Articles

EBV-Infected NKTCL Upregulated MHC-II Imprinted T Cell Exhaustion By Interacting with LAG3

Shanshan Zhang, Zhang Hanzhen, Chen Huan, Yuqi Wang, Youhai Yuan, Xiaolei Wei, Qifa Liu

Blood (2024) 144 (Supplement 1): 4372.

https://doi.org/10.1182/blood-2024-200751

Published: 2024

NARROW

High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial

TET2 Deficiency Cooperates with MSH6 Mutation to Promote the Progression of MDS/MPN through Increasing Tumor Stem Cell Frequency

Ursolic Acid Alleviates the Injurious Effects of Busulfan Plus Cyclophosphamide on Hepatic Sinusoidal Endothelial Cells By Inhibiting the TNFα/NF-Κb Signaling Pathway

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Reduced Incidence of Severe Hemorrhagic Cystitis in Prophylaxis Infusion of Mensenchymal Stromal Cells for Gvhd, a Secondary Endpoints in a Randomized,Multiple Center Clinical Tria

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Intensified Conditioning Containing Decitabine Versus Standard Myeloablative Conditioning for Adult Patients with KMT2A-Rearranged Leukemia: A Multicenter Retrospective Study

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study

Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

Clinical Characteristics and Risk Factors of Chronic Kidney Disease Among Patients with Myeloproliferative Neoplasms

Quantitative Detection of the Expressions of BCL-2, BCL-Xl and MCL-1 in Bone Marrow Tissues with Immunofluorescence Might Predict the Efficacy of Venetoclax-Based Therapies in Acute Myeloid Leukemia

Drug-Resistant Hematological Malignancies Organoids Can be Established By Magic-PDX Model Strategy

ABC Regimen: Combination of 3rd Generation TKI Olverembatinib, Blinatumomab and Chidamide for Older New Diagnosed Ph-Positive ALL Patients

BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Donor Neutrophil Subsets in G-CSF Mobilized Peripheral Blood Stem Cell to Predict the Risk of Agvhd

EBV-Infected NKTCL Upregulated MHC-II Imprinted T Cell Exhaustion By Interacting with LAG3

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only